Home › Funds › Orbis Allan Gray Ltd › SRRK
Orbis Allan Gray Ltd position in SRRK
SCHOLAR ROCK HLDG CORP · Health Care
Orbis Allan Gray Ltd reported holding 5,933,533 shares of SRRK (SCHOLAR ROCK HLDG CORP) in its Q2 2026 13F filing — a position valued at US$326.3M, representing 1.12% of its reported portfolio and ranking #31 among its reported holdings. Orbis Allan Gray Ltd has disclosed SRRK holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Orbis Allan Gray Ltd's SRRK position evolved
Orbis Allan Gray Ltd first disclosed a stake in SRRK in Q3 2025 at 302,252 shares (US$11.3M). The position peaked in Q2 2026 at 5,933,533 shares, worth US$326.3M. Across 4 filings, Orbis Allan Gray Ltd increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 5,933,533 shares valued at US$326.3M — an increase of 1,753,550 shares quarter over quarter.. Notable position changes include a 1034% increase in Q4 2025 (shares rose 12% over the following quarter), a 42% increase in Q2 2026 (shares fell 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 302.25K | $11.26M | New |
| Q4 2025 | 3.43M | $151.04M | Add |
| Q1 2026 | 4.18M | $205.49M | Add |
| Q2 2026 | 5.93M | $326.34M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SRRK and 13F data
SRRK (SCHOLAR ROCK HLDG CORP) is a Health Care company. 53 other funds we track also report a position in SRRK — the largest reported positions include Siren, L.L.C. (US$526.6M), Samsara BioCapital, LLC (US$379.4M), Redmile Group, LLC (US$237.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SRRK
- Siren, L.L.C. 9.58M sh · $526.63M · Q2 2026
- Samsara BioCapital, LLC 6.90M sh · $379.37M · Q2 2026
- Redmile Group, LLC 4.31M sh · $237.11M · Q2 2026
- Bellevue Group AG 2.45M sh · $134.73M · Q2 2026
- Hood River Capital Management LLC 2.22M sh · $122.36M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 2.21M sh · $121.31M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 2.11M sh · $116.13M · Q2 2026
- Integral Health Asset Management, LLC 750.00K sh · $41.25M · Q2 2026
- Rock Springs Capital Management LP 715.45K sh · $39.35M · Q2 2026
- Casdin Capital 665.00K sh · $36.58M · Q2 2026
- Eagle Health Investments LP 555.27K sh · $30.54M · Q2 2026
More on Orbis Allan Gray Ltd
FAQ
How long has Orbis Allan Gray Ltd held SRRK?
Orbis Allan Gray Ltd has disclosed SRRK holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is Orbis Allan Gray Ltd's current position in SRRK?
As of Q2 2026, Orbis Allan Gray Ltd holds 5.93M shares of SRRK (SCHOLAR ROCK HLDG CORP), valued at $326.34M, representing 1.12% of its reported portfolio and ranking #31.
Has Orbis Allan Gray Ltd been buying or selling SRRK?
In the latest 13F filing (Q2 2026), Orbis Allan Gray Ltd increased its position in SRRK. The position peaked in Q2 2026 at 5.93M shares.
Which other funds hold SRRK?
Other major institutional holders of SRRK include Siren, L.L.C., Samsara BioCapital, LLC, Redmile Group, LLC, among 53 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.